Background Balsalazide is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease. It is a prodrug of mesalamine which has an inert carrier molecule instead of the sulfapyridine moiety of sulfasalazine. Balsalazide is metabolised by bacterial azo reductases in the colon to release mesalamine. It is an effective first-line agent for patients with ulcerative colitis, both for the …
Read More »